The Chemours Company
CC
$12.37
-$0.07-0.56%
NYSE
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -7.13% | -2.41% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -7.13% | -2.41% | |||
| Cost of Revenue | -7.74% | -1.38% | |||
| Gross Profit | -4.55% | -6.54% | |||
| SG&A Expenses | 82.57% | -28.29% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -0.52% | -4.04% | |||
| Operating Income | -67.57% | 15.63% | |||
| Income Before Tax | 130.00% | -136.59% | |||
| Income Tax Expenses | 666.67% | -125.00% | |||
| Earnings from Continuing Operations | 70.37% | -138.57% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 70.37% | -138.57% | |||
| EBIT | -67.57% | 15.63% | |||
| EBITDA | -44.25% | 11.88% | |||
| EPS Basic | 70.40% | -138.51% | |||
| Normalized Basic EPS | -108.42% | 35.45% | |||
| EPS Diluted | 66.91% | -139.22% | |||
| Normalized Diluted EPS | -108.42% | 36.10% | |||
| Average Basic Shares Outstanding | 0.09% | 0.19% | |||
| Average Diluted Shares Outstanding | 0.09% | -0.28% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | -2.20% | -3.66% | |||